Theriva Biologics
Price & Volume
Stats
See moreOpen | $0.17 |
Previous Close | $0.18 |
Day Range | $0.17-$0.19 |
52W Range | $0.13-$0.49 |
Market Cap | $8.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $300,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $300,000 |
Diluted EPS | $0.73 |
News
See moreYahoo Finance • 7 months ago
Theriva Biologics To Present VIRAGE Data; Stock Jumps
Yahoo Finance • 7 months ago
Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026
Yahoo Finance • 7 months ago
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
Yahoo Finance • 8 months ago
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del ejercicio 2025
About
CEO | Mr. Steven A. Shallcross CPA |
CFO | Mr. Steven A. Shallcross CPA |
Address | 9605 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |